{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:35:58Z","timestamp":1791653758056,"version":"4.3.4"},"reference-count":52,"publisher":"American Society for Microbiology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We evaluated the immunogenicity and protective efficacy of a DNA vaccine expressing codon-optimized envelope glycoprotein genes of Venezuelan equine encephalitis virus (VEEV) when delivered by intramuscular electroporation. Mice vaccinated with the DNA vaccine developed robust VEEV-neutralizing antibody responses that were comparable to those observed after administration of the live-attenuated VEEV vaccine TC-83 and were completely protected from a lethal aerosol VEEV challenge. The DNA vaccine also elicited strong neutralizing antibody responses in rabbits that persisted at high levels for at least 6 months and could be boosted by a single additional electroporation administration of the DNA performed approximately 6 months after the initial vaccinations. Cynomolgus macaques that received the vaccine by intramuscular electroporation developed substantial neutralizing antibody responses and after an aerosol challenge had no detectable serum viremia and had reduced febrile reactions, lymphopenia, and clinical signs of disease compared to those of negative-control macaques. Taken together, our results demonstrate that this DNA vaccine provides a potent means of protecting against VEEV infections and represents an attractive candidate for further development.<\/jats:p>","DOI":"10.1128\/cvi.00030-11","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T03:40:14Z","timestamp":1301542814000},"page":"707-716","source":"Crossref","is-referenced-by-count":74,"title":["A DNA Vaccine for Venezuelan Equine Encephalitis Virus Delivered by Intramuscular Electroporation Elicits High Levels of Neutralizing Antibodies in Multiple Animal Models and Provides Protective Immunity to Mice and Nonhuman Primates"],"prefix":"10.1128","volume":"18","author":[{"given":"Lesley C.","family":"Dupuy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Ellefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Luxembourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Hannaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie S.","family":"Schmaljohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2011,3,30]]},"reference":[{"key":"key20180919073511_B1","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1128\/JVI.02075-06","article-title":"Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression","volume":"81","author":"Aguilar","year":"2007","journal-title":"J. Virol."},{"key":"key20180919073511_B2","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JVI.02554-09","article-title":"Venezuelan equine encephalitis virus capsid protein forms a tetrameric complex with CRM1 and importin alpha\/beta that obstructs nuclear pore complex function","volume":"84","author":"Atasheva","year":"2010","journal-title":"J. Virol."},{"key":"key20180919073511_B3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0025-7125(16)30270-X","article-title":"Viral encephalitis","volume":"77","author":"Bale","year":"1993","journal-title":"Med. Clin. North Am."},{"key":"key20180919073511_B4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0264-410X(00)00123-7","article-title":"An immunological profile of BALB\/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine","volume":"19","author":"Bennett","year":"2000","journal-title":"Vaccine"},{"key":"key20180919073511_B5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mt.2009.5","article-title":"Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments","volume":"17","author":"Bodles-Brakhop","year":"2009","journal-title":"Mol. Ther."},{"key":"key20180919073511_B6","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1128\/JVI.02545-09","article-title":"T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody","volume":"84","author":"Brooke","year":"2010","journal-title":"J. Virol."},{"key":"key20180919073511_B7","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1128\/JVI.77.8.4928-4937.2003","article-title":"A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies","volume":"77","author":"Cid-Arregui","year":"2003","journal-title":"J. Virol."},{"key":"key20180919073511_B8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/AEM.25.2.262-265.1973","article-title":"Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells","volume":"25","author":"Cole","year":"1973","journal-title":"Appl. Microbiol."},{"key":"key20180919073511_B9","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1128\/JVI.75.22.10991-11001.2001","article-title":"Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein","volume":"75","author":"Deml","year":"2001","journal-title":"J. Virol."},{"key":"key20180919073511_B10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4269\/ajtmh.1979.28.329","article-title":"Ten clinical cases of human infection with Venezuelan equine encephalomyelitis virus, subtype I-D","volume":"28","author":"Dietz","year":"1979","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"key20180919073511_B11","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2009.04.049","article-title":"Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine","volume":"27","author":"Dupuy","year":"2009","journal-title":"Vaccine"},{"key":"key20180919073511_B12","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1016\/j.vaccine.2010.09.005","article-title":"Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates","volume":"28","author":"Dupuy","year":"2010","journal-title":"Vaccine"},{"key":"key20180919073511_B13","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1586\/erv.09.132","article-title":"DNA vaccines for biodefense","volume":"8","author":"Dupuy","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"key20180919073511_B14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jmv.10086","article-title":"Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus","volume":"67","author":"Elvin","year":"2002","journal-title":"J. Med. Virol."},{"key":"key20180919073511_B15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0272-2712(18)30018-0","article-title":"Clinical recognition and management of patients exposed to biological warfare agents","volume":"21","author":"Franz","year":"2001","journal-title":"Clin. Lab. Med."},{"key":"key20180919073511_B16","doi-asserted-by":"crossref","first-page":"13552","DOI":"10.1128\/JVI.01576-07","article-title":"Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription","volume":"81","author":"Garmashova","year":"2007","journal-title":"J. Virol."},{"key":"key20180919073511_B17","first-page":"917","article-title":"Alphaviruses","volume-title":"Fields virology","author":"Griffin","year":"2001"},{"key":"key20180919073511_B18","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.158.3806.1283","article-title":"Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards","volume":"158","author":"Hanson","year":"1967","journal-title":"Science"},{"key":"key20180919073511_B19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0264-410X(01)00337-1","article-title":"Onset and duration of protective immunity to IA\/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice","volume":"20","author":"Hart","year":"2001","journal-title":"Vaccine"},{"key":"key20180919073511_B20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0264-410X(96)00204-6","article-title":"Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB\/c, but not C3H\/HeN mice","volume":"15","author":"Hart","year":"1997","journal-title":"Vaccine"},{"key":"key20180919073511_B21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0264-410X(98)00335-1","article-title":"Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors","volume":"17","author":"Hodgson","year":"1999","journal-title":"Vaccine"},{"key":"key20180919073511_B22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0264-410X(95)93315-Z","article-title":"Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses","volume":"13","author":"Hunt","year":"1995","journal-title":"Vaccine"},{"key":"key20180919073511_B23","volume-title":"Guide for the care and use of laboratory animals","author":"Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council","year":"1996"},{"key":"key20180919073511_B24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/JCM.19.3.429-431.1984","article-title":"Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters","volume":"19","author":"Jahrling","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073511_B25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-1702(02)00275-7","article-title":"Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice","volume":"91","author":"Jones","year":"2003","journal-title":"Virus Res."},{"key":"key20180919073511_B26","first-page":"21","article-title":"Bioterrorism","volume":"63","author":"Kortepeter","year":"2001","journal-title":"J. Environ. Health"},{"key":"key20180919073511_B27","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.vaccine.2009.10.111","article-title":"Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques","volume":"28","author":"Livingston","year":"2010","journal-title":"Vaccine"},{"key":"key20180919073511_B28","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2005.08.014","article-title":"Enhancement of immune responses to an HBV DNA vaccine by electroporation","volume":"24","author":"Luxembourg","year":"2006","journal-title":"Vaccine"},{"key":"key20180919073511_B29","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1016\/j.vaccine.2008.03.064","article-title":"Potentiation of an anthrax DNA vaccine with electroporation","volume":"26","author":"Luxembourg","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073511_B30","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2008.05.021","article-title":"Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens","volume":"26","author":"Luxembourg","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073511_B31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4269\/ajtmh.1963.12.597","article-title":"Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man","volume":"12","author":"McKinney","year":"1963","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"key20180919073511_B32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4269\/ajtmh.1999.60.630","article-title":"Geographic distribution of Venezuelan equine encephalitis virus subtype IE genotypes in Central America and Mexico","volume":"60","author":"Oberste","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"key20180919073511_B33","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2009.07.095","article-title":"Vaccines for Venezuelan equine encephalitis","volume":"27","author":"Paessler","year":"2009","journal-title":"Vaccine"},{"key":"key20180919073511_B34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.virol.2007.05.041","article-title":"Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection","volume":"367","author":"Paessler","year":"2007","journal-title":"Virology"},{"key":"key20180919073511_B35","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0264-410X(01)00505-9","article-title":"Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus","volume":"20","author":"Phillpotts","year":"2002","journal-title":"Vaccine"},{"key":"key20180919073511_B36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"key20180919073511_B37","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"key":"key20180919073511_B38","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0264-410X(97)00192-8","article-title":"Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates","volume":"16","author":"Pratt","year":"1998","journal-title":"Vaccine"},{"key":"key20180919073511_B39","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"Reed","year":"2005","journal-title":"Vaccine"},{"key":"key20180919073511_B40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1086\/382281","article-title":"Aerosol infection of cynomolgus macaques with enzootic strains of Venezuelan equine encephalitis viruses","volume":"189","author":"Reed","year":"2004","journal-title":"J. Infect. Dis."},{"key":"key20180919073511_B41","unstructured":"ReedS. D. LiS.. 1 August 2009, posting date. Electroporation advances in large animals. Curr. Gene Ther. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3046214\/pdf\/nihms175545.pdf."},{"key":"key20180919073511_B42","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"key":"key20180919073511_B43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0042-6822(85)90343-5","article-title":"The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes","volume":"142","author":"Roehrig","year":"1985","journal-title":"Virology"},{"key":"key20180919073511_B44","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1016\/j.vaccine.2008.03.097","article-title":"Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters","volume":"26","author":"Spik","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073511_B45","first-page":"241","article-title":"Alphavirus encephalitides","author":"Steele","year":"2007","journal-title":"Medical aspects of biological warfare"},{"key":"key20180919073511_B46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-1759(90)90464-7","article-title":"Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay","volume":"128","author":"Taguchi","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"key20180919073511_B47","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1016\/j.vaccine.2007.07.025","article-title":"Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus","volume":"25","author":"Ternette","year":"2007","journal-title":"Vaccine"},{"key":"key20180919073511_B48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0891-5520(20)30389-5","article-title":"Arboviral infections in the United States","volume":"5","author":"Tsai","year":"1991","journal-title":"Infect. Dis. Clin. North Am."},{"key":"key20180919073511_B49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1586\/erv.10.42","article-title":"Electroporation for DNA immunization: clinical application","volume":"9","author":"van Drunen Littel-van den Hurk","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"key20180919073511_B50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0042-6822(92)90190-Z","article-title":"Phylogenetic analysis of alphaviruses in the Venezuelan equine encephalitis complex and identification of the source of epizootic viruses","volume":"191","author":"Weaver","year":"1992","journal-title":"Virology"},{"key":"key20180919073511_B51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-6-118","article-title":"Improved efficacy of a gene optimised adenovirus-based vaccine for Venezuelan equine encephalitis virus","volume":"6","author":"Williams","year":"2009","journal-title":"Virol. J."},{"key":"key20180919073511_B52","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2009.04.015","article-title":"CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus","volume":"27","author":"Yun","year":"2009","journal-title":"Vaccine"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00030-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T22:44:00Z","timestamp":1637448240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00030-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,30]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,5,3]]},"published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1128\/CVI.00030-11"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00030-11","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,30]]}}}